Biogen (BIIB) option implied volatility increases

Biogen (NASDAQ: BIIB) September weekly call option implied volatility is at 121, October is at 112; compared to its 52-week range of 29 to 97 into topline phase 3 data for Alzheimer's drug lecanemab.

You May Also Be Interested In

• Autodesk (ADSK) call put ratio 1.4 calls to 1 puts into quarter results
• Hormel Foods (HRL) call put ratio 1 call to 1.1 puts into quarter results
• SentinelOne, Inc. (S) call put ratio 1.3 calls to 1 put with a focus on August 25 weekly calls into quarter results